Concentrix [CNXC] vs International [IBM] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Concentrix wins in 10 metrics, International wins in 9 metrics, with 0 ties. Concentrix appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricConcentrixInternationalBetter
P/E Ratio (TTM)10.2246.59Concentrix
Price-to-Book Ratio0.699.77Concentrix
Debt-to-Equity Ratio111.13245.47Concentrix
PEG Ratio0.022.51Concentrix
EV/EBITDA5.2622.63Concentrix
Profit Margin (TTM)3.25%9.11%International
Operating Margin (TTM)5.92%18.32%International
EBITDA Margin (TTM)5.92%18.32%International
Return on Equity7.43%22.67%International
Return on Assets (TTM)3.85%4.81%International
Free Cash Flow (TTM)$428.73M$11.76BInternational
Dividend Yield3.51%1.77%Concentrix
1-Year Return-0.83%24.08%International
Price-to-Sales Ratio (TTM)0.314.19Concentrix
Enterprise Value$7.48B$320.97BInternational
EV/Revenue Ratio0.775.01Concentrix
Gross Profit Margin (TTM)N/A58.77%N/A
Revenue per Share (TTM)$153$69Concentrix
Earnings per Share (Diluted)$4.72$6.19International
Beta (Stock Volatility)0.550.72Concentrix
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Concentrix vs International Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Concentrix-1.49%-0.61%-9.52%-16.13%0.74%9.19%
International0.36%3.44%13.01%-1.04%28.19%31.59%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Concentrix-0.83%-59.61%-40.58%-40.58%-40.58%-40.58%
International24.08%141.10%140.40%101.29%114.61%267.61%

News Based Sentiment: Concentrix vs International

Concentrix

News based Sentiment: MIXED

Concentrix reported mixed Q3 results with a revenue beat but EPS and EBITDA misses, leading to lowered guidance. However, the company continues to invest in AI and return capital to shareholders, creating a complex investment narrative with both positive and negative elements.

View Concentrix News Sentiment Analysis

International

News based Sentiment: POSITIVE

IBM's October developments centered around significant investments and partnerships in the AI space, coupled with strong financial results and positive analyst revisions. While institutional investment activity was mixed, the overall narrative points towards a strengthening position in a key growth market, making this a noteworthy month for investors.

View International News Sentiment Analysis

Performance & Financial Health Analysis: Concentrix vs International

MetricCNXCIBM
Market Information
Market Cap i$3.10B$270.67B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i1,434,8805,867,170
90 Day Avg. Volume i944,1334,812,477
Last Close$47.54$289.42
52 Week Range$36.28 - $66.00$203.51 - $296.16
% from 52W High-27.97%-2.28%
All-Time High$208.48 (Feb 07, 2022)$296.16 (Jun 25, 2025)
% from All-Time High-77.20%-2.28%
Growth Metrics
Quarterly Revenue Growth0.04%0.08%
Quarterly Earnings Growth4.30%0.20%
Financial Health
Profit Margin (TTM) i0.03%0.09%
Operating Margin (TTM) i0.06%0.18%
Return on Equity (TTM) i0.07%0.23%
Debt to Equity (MRQ) i111.13245.47
Cash & Liquidity
Book Value per Share (MRQ)$69.83$29.53
Cash per Share (MRQ)$5.63$16.58
Operating Cash Flow (TTM) i$648.78M$13.28B
Levered Free Cash Flow (TTM) i$3.74B$13.86B
Dividends
Last 12-Month Dividend Yield i3.51%1.77%
Last 12-Month Dividend i$1.68$5.01

Valuation & Enterprise Metrics Analysis: Concentrix vs International

MetricCNXCIBM
Price Ratios
P/E Ratio (TTM) i10.2246.59
Forward P/E i3.9227.18
PEG Ratio i0.022.51
Price to Sales (TTM) i0.314.19
Price to Book (MRQ) i0.699.77
Market Capitalization
Market Capitalization i$3.10B$270.67B
Enterprise Value i$7.48B$320.97B
Enterprise Value Metrics
Enterprise to Revenue i0.775.01
Enterprise to EBITDA i5.2622.63
Risk & Other Metrics
Beta i0.550.72
Book Value per Share (MRQ) i$69.83$29.53

Financial Statements Comparison: Concentrix vs International

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)CNXCIBM
Revenue/Sales i$2.37B$16.98B
Cost of Goods Sold i$1.52B$7.00B
Gross Profit i$855.90M$9.98B
Research & Development iN/A$2.10B
Operating Income (EBIT) i$168.87M$3.09B
EBITDA i$334.50M$4.54B
Pre-Tax Income i$100.79M$2.60B
Income Tax i$30.54M$404.00M
Net Income (Profit) i$70.26M$2.19B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)CNXCIBM
Cash & Equivalents i$308.00M$11.04B
Total Current Assets i$2.96B$35.34B
Total Current Liabilities i$1.79B$35.11B
Long-Term Debt i$4.90B$59.12B
Total Shareholders Equity i$4.03B$26.95B
Retained Earnings i$1.24B$150.70B
Property, Plant & Equipment i$0$21.15B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)CNXCIBM
Operating Cash Flow i$231.10M$2.63B
Capital Expenditures i$-55.79M$-170.00M
Free Cash Flow i$180.74M$3.98B
Debt Repayment i$-1.45B$-1.26B
Common Stock Repurchase i$-46.82M$-284.00M

Short Interest & Institutional Ownership Analysis

MetricCNXCIBM
Shares Short i7.66M14.63M
Short Ratio i12.273.76
Short % of Float i0.15%0.02%
Average Daily Volume (10 Day) i1,434,8805,867,170
Average Daily Volume (90 Day) i944,1334,812,477
Shares Outstanding i64.24M926.29M
Float Shares i35.03M929.40M
% Held by Insiders i0.16%0.00%
% Held by Institutions i0.98%0.65%

Dividend Analysis & Yield Comparison: Concentrix vs International

MetricCNXCIBM
Last 12-Month Dividend i$1.68$5.01
Last 12-Month Dividend Yield i3.51%1.77%
3-Year Avg Annual Dividend i$1.33$6.09
3-Year Avg Dividend Yield i0.49%1.04%
3-Year Total Dividends i$4.00$18.27
Ex-Dividend DateOct 24, 2025Feb 10, 2025